Close Menu

NEW YORK (GenomeWeb) – Rosetta Genomics today said that it plans to redirect "substantially all of our sales and marketing resources" to promote is RosettaGx Reveal test, following a preliminary 54 percent quarter over quarter growth in sales of the microRNA-based assay for classifying indeterminate thyroid nodules.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

A study of Great Danes homes in on a genomic region linked to fearfulness.

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.